Search

Randeep Singh

Examiner (ID: 377)

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
524
Issued Applications
328
Pending Applications
7
Abandoned Applications
192

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16663785 [patent_doc_number] => 10933007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Composition comprising the combination of specific alkoxysilanes and of a surfactant [patent_app_type] => utility [patent_app_number] => 16/061858 [patent_app_country] => US [patent_app_date] => 2016-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7747 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061858 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/061858
Composition comprising the combination of specific alkoxysilanes and of a surfactant Dec 13, 2016 Issued
Array ( [id] => 13729243 [patent_doc_number] => 20180369089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => COSMETIC COMPOSITION COMPRISING AN ANIONIC SURFACTANT, AT LEAST 3.5% BY WEIGHT OF A FATTY ACID AND AN ANTIDANDRUFF AGENT [patent_app_type] => utility [patent_app_number] => 16/062268 [patent_app_country] => US [patent_app_date] => 2016-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062268 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/062268
Cosmetic composition comprising an anionic surfactant, at least 3.5% by weight of a fatty acid and an antidandruff agent Dec 12, 2016 Issued
Array ( [id] => 11704295 [patent_doc_number] => 20170172794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'Reservoir Device for Intraocular Drug Delivery' [patent_app_type] => utility [patent_app_number] => 15/366982 [patent_app_country] => US [patent_app_date] => 2016-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6853 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366982 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/366982
Reservoir Device for Intraocular Drug Delivery Nov 30, 2016 Abandoned
Array ( [id] => 11662447 [patent_doc_number] => 20170151149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'TOPICAL SKIN COMPOSITIONS HAVING PROTEINS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/365045 [patent_app_country] => US [patent_app_date] => 2016-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38153 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365045 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/365045
TOPICAL SKIN COMPOSITIONS HAVING PROTEINS AND METHODS OF USE Nov 29, 2016 Abandoned
Array ( [id] => 11809066 [patent_doc_number] => 09713624 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-07-25 [patent_title] => 'Synthesis of rutin nanotubes' [patent_app_type] => utility [patent_app_number] => 15/364225 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 1776 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364225 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/364225
Synthesis of rutin nanotubes Nov 28, 2016 Issued
Array ( [id] => 11497929 [patent_doc_number] => 20170072115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'DRUG ELUTING COMPOSITE' [patent_app_type] => utility [patent_app_number] => 15/362008 [patent_app_country] => US [patent_app_date] => 2016-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 12065 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15362008 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/362008
Drug eluting composite Nov 27, 2016 Issued
Array ( [id] => 11491339 [patent_doc_number] => 20170065524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent' [patent_app_type] => utility [patent_app_number] => 15/354473 [patent_app_country] => US [patent_app_date] => 2016-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20326 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354473 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/354473
Pharmaceutical Formulation Containing Gelling Agent Nov 16, 2016 Abandoned
Array ( [id] => 11491340 [patent_doc_number] => 20170065525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent' [patent_app_type] => utility [patent_app_number] => 15/354538 [patent_app_country] => US [patent_app_date] => 2016-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20325 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354538 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/354538
Pharmaceutical formulation containing gelling agent Nov 16, 2016 Issued
Array ( [id] => 15708513 [patent_doc_number] => 20200101022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => FORMULATIONS OF CYSTEAMINE AND CYSTAMINE [patent_app_type] => utility [patent_app_number] => 16/461361 [patent_app_country] => US [patent_app_date] => 2016-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461361 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/461361
Formulations of cysteamine and cystamine Nov 15, 2016 Issued
Array ( [id] => 15949011 [patent_doc_number] => 10662395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-26 [patent_title] => Odor neutralizer for ammonia and primary or secondary amines [patent_app_type] => utility [patent_app_number] => 15/768054 [patent_app_country] => US [patent_app_date] => 2016-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7136 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768054 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/768054
Odor neutralizer for ammonia and primary or secondary amines Nov 15, 2016 Issued
Array ( [id] => 15694355 [patent_doc_number] => 10603338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-31 [patent_title] => Method for poly signal activation of apoptosis of malignant solid tumour cells [patent_app_type] => utility [patent_app_number] => 15/757285 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4014 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757285 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/757285
Method for poly signal activation of apoptosis of malignant solid tumour cells Oct 20, 2016 Issued
Array ( [id] => 11567351 [patent_doc_number] => 20170105996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE' [patent_app_type] => utility [patent_app_number] => 15/294075 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20537 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/294075
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE Oct 13, 2016 Abandoned
Array ( [id] => 16320152 [patent_doc_number] => 10780099 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Injectable neurosteroid formulations containing nanoparticles [patent_app_type] => utility [patent_app_number] => 15/294135 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 16124 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294135 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/294135
Injectable neurosteroid formulations containing nanoparticles Oct 13, 2016 Issued
Array ( [id] => 12143689 [patent_doc_number] => 09877924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-30 [patent_title] => 'Pharmaceutical formulation containing gelling agent' [patent_app_type] => utility [patent_app_number] => 15/284706 [patent_app_country] => US [patent_app_date] => 2016-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20544 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284706 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/284706
Pharmaceutical formulation containing gelling agent Oct 3, 2016 Issued
Array ( [id] => 13457509 [patent_doc_number] => 20180280297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => NO-RINSE CHEMICAL FOAM CONTAINING TRIFAROTENE, AND USE THEREOF IN THE TREATMENT OF ACNE [patent_app_type] => utility [patent_app_number] => 15/763685 [patent_app_country] => US [patent_app_date] => 2016-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763685 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/763685
No-rinse chemical foam containing trifarotene, and use thereof in the treatment of acne Sep 26, 2016 Issued
Array ( [id] => 13457511 [patent_doc_number] => 20180280298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => NO-RINSE CHEMICAL FOAM CONTAINING TRIFAROTENE, AND USE THEREOF IN THE TREATMENT OF ICHTHYOSIS [patent_app_type] => utility [patent_app_number] => 15/763753 [patent_app_country] => US [patent_app_date] => 2016-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763753 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/763753
No-rinse chemical foam containing trifarotene, and use thereof in the treatment of ichthyosis Sep 26, 2016 Issued
Array ( [id] => 13397385 [patent_doc_number] => 20180250235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => FINGOLIMOD CAPSULE COMPOSITION [patent_app_type] => utility [patent_app_number] => 15/760550 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760550 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/760550
FINGOLIMOD CAPSULE COMPOSITION Sep 15, 2016 Abandoned
Array ( [id] => 13672821 [patent_doc_number] => 20160375144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 15/262143 [patent_app_country] => US [patent_app_date] => 2016-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262143 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/262143
MetAP-2 inhibitor polymersomes for therapeutic administration Sep 11, 2016 Issued
Array ( [id] => 15173893 [patent_doc_number] => 20190357538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-28 [patent_title] => An Antifungal Composition Comprising Natamycin and C4-C22 Fatty Acids, Monoglycerides of These Fatty Acids and/or Derivatives of These Fatty Acids [patent_app_type] => utility [patent_app_number] => 15/759026 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759026 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/759026
An Antifungal Composition Comprising Natamycin and C4-C22 Fatty Acids, Monoglycerides of These Fatty Acids and/or Derivatives of These Fatty Acids Sep 8, 2016 Abandoned
Array ( [id] => 11335672 [patent_doc_number] => 20160361428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 15/248043 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 43652 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15248043 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/248043
MetAP-2 inhibitor polymersomes for therapeutic administration Aug 25, 2016 Issued
Menu